GEHC · GE HealthCare Technologies Inc. · Financials

Verified covenant terms

• Section 5.02 · Keeping of Books.

  Governing rule: ARTICLE V

  Governing rule: AFFIRMATIVE COVENANTS

  Governing rule: The Borrower hereby agrees that, so long as the Commitments remain in effect or any Obligation or other amount is owing to any Lender or the Administrative Agent hereunder, the Borrower shall:

  Keep proper books and records and maintain properties useful and necessary in its business except as would not reasonably be expected to have a Material Adverse Effect. Applies to every series under this agreement Exceptions: except as would not reasonably be expected to have a Material Adverse Effect SECTION 5.02. Keeping of Books.
  Full wording and supporting evidence

  Source evidence: SECTION 5.02. Keeping of Books. Keep proper books and records and maintain properties useful and necessary in its business except as would not reasonably be expected to have a Material Adverse Effect.

  Target identity evidence: 364-DAY REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of February 26, 2026, among GE HEALTHCARE TECHNOLOGIES INC. (the “Borrower”), the Lenders (as defined below) party hereto and JPMORGAN CHASE BANK, N.A., as the Administrative Agent (as defined below).

• Section 5.03 · Preservation of Existence

  Governing rule: ARTICLE V

  Governing rule: AFFIRMATIVE COVENANTS

  Governing rule: The Borrower hereby agrees that, so long as the Commitments remain in effect or any Obligation or other amount is owing to any Lender or the Administrative Agent hereunder, the Borrower shall:

  SECTION 5.03. Preservation of Existence. (a) Preserve and maintain its existence and (b) comply in all material respects with all applicable laws, rules, regulations and orders, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided, however, in the case of the foregoing clause (a), the Borrower may consummate any merger or consolidation or other transaction permitted under Section 6.01. Applies to every series under this agreement Exceptions: where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided, however, in the case of the foregoing clause (a), the Borrower may consummate any merger or consolidation or other transaction permitted under Section 6.01 SECTION 5.03. Preservation of Existence.
  Full wording and supporting evidence

  Source evidence: SECTION 5.03. Preservation of Existence. (a) Preserve and maintain its existence and (b) comply in all material respects with all applicable laws, rules, regulations and orders, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided, however, in the case of the foregoing clause (a), the Borrower may consummate any merger or consolidation or other transaction permitted under Section 6.01.

  Target identity evidence: 364-DAY REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of February 26, 2026, among GE HEALTHCARE TECHNOLOGIES INC. (the “Borrower”), the Lenders (as defined below) party hereto and JPMORGAN CHASE BANK, N.A., as the Administrative Agent (as defined below).

• Section 5.03 · Preservation of Existence.

  Governing rule: ARTICLE V

  Governing rule: AFFIRMATIVE COVENANTS

  Governing rule: The Borrower hereby agrees that, so long as the Commitments remain in effect or any Obligation or other amount is owing to any Lender or the Administrative Agent hereunder, the Borrower shall:

  (a) Preserve and maintain its existence and (b) comply in all material respects with all applicable laws, rules, regulations and orders, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided, however, in the case of the foregoing clause (a), the Borrower may consummate any merger or consolidation or other transaction permitted under Section 6.01. Applies to every series under this agreement Exceptions: except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided, however, in the case of the foregoing clause (a), the Borrower may consummate any merger or consolidation or other transaction permitted under Section 6.01. SECTION 5.03. Preservation of Existence.
  Full wording and supporting evidence

  Source evidence: SECTION 5.03. Preservation of Existence. (a) Preserve and maintain its existence and (b) comply in all material respects with all applicable laws, rules, regulations and orders, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided, however, in the case of the foregoing clause (a), the Borrower may consummate any merger or consolidation or other transaction permitted under Section 6.01.

  Target identity evidence: 364-DAY REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of February 26, 2026, among GE HEALTHCARE TECHNOLOGIES INC. (the “Borrower”), the Lenders (as defined below) party hereto and JPMORGAN CHASE BANK, N.A., as the Administrative Agent (as defined below).

• Section 5.02 · Keeping of Books

  Governing rule: ARTICLE V

  Governing rule: AFFIRMATIVE COVENANTS

  Governing rule: The Borrower hereby agrees that, so long as the Commitments remain in effect or any Obligation or other amount is owing to any Lender or the Administrative Agent hereunder, the Borrower shall:

  Keep proper books and records and maintain properties useful and necessary in its business except as would not reasonably be expected to have a Material Adverse Effect. Applies to every series under this agreement Exceptions: except as would not reasonably be expected to have a Material Adverse Effect SECTION 5.02. Keeping of Books.
  Full wording and supporting evidence

  Source evidence: SECTION 5.02. Keeping of Books. Keep proper books and records and maintain properties useful and necessary in its business except as would not reasonably be expected to have a Material Adverse Effect.

  Target identity evidence: 364-DAY REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of February 26, 2026, among GE HEALTHCARE TECHNOLOGIES INC. (the “Borrower”), the Lenders (as defined below) party hereto and JPMORGAN CHASE BANK, N.A., as the Administrative Agent (as defined below).

• Section 2.18 · Use of Proceeds. SECTION 2.18. Use of Proceeds. The proceeds of any Borrowing shall be available (and the Borrower agrees that it shall use such proceeds) for general corporate purposes of the Borrower and its Subsidiaries. Applies to every series under this agreement Exceptions: except to the extent permitted to be conducted by a Person required to comply with Sanctions SECTION 2.18. Use of Proceeds.
  Full wording and supporting evidence

  Source evidence: SECTION 2.18. Use of Proceeds. The proceeds of any Borrowing shall be available (and the Borrower agrees that it shall use such proceeds) for general corporate purposes of the Borrower and its Subsidiaries. The Borrower will not request any Borrowing, and the Borrower will not, and will procure that its Subsidiaries and its or their respective directors, officers, employees and agents will not, use the proceeds of any Loans (a) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (b) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, except to the extent permitted to be conducted by a Person required to comply with Sanctions, or (c) in any manner that would result in the violation of any Sanctions applicable to any party hereto.

  Target identity evidence: 364-DAY REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of February 26, 2026, among GE HEALTHCARE TECHNOLOGIES INC. (the “Borrower”), the Lenders (as defined below) party hereto and JPMORGAN CHASE BANK, N.A., as the Administrative Agent (as defined below).